Synlogic

Home » Synlogic

Secondary

Synlogic

Synlogic is pioneering the development of a novel class of living medicines, Synthetic Biotic medicines, based on its proprietary drug development platform.

Symbol

SYBX

Last Closing Price
$10.71

Shares
4,700,000

Effective Date
January 24, 2018

Underwriters
Leerink Partners, Piper Jaffray

To view the prospectus for Synlogic, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253